Elenco degli articoli con argomento «idrosadenite suppurativa»
Dermatologia12 ott 2026
Inflammatory Bowel Disease and Interleukin-17 Inhibitors in Hidradenitis Suppurativa
Interleukin (IL)-17 inhibitors have emerged as effective therapies for moderate to severe hidradenitis suppurativa (HS)
25 set 2026
Effect of semaglutide on hidradenitis suppurativa disease
Effect of semaglutide
25 set 2026
Systemic Inflammatory Indexes as Easy-to-Use Markers for Monitoring Psoriasis
Systemic Inflammatory Indexes as Easy-to-Use Markers
05 mag 2026
International consensus statement on the use of ultrasound
So far, the evidence on the use of ultrasound (US) in hidradenitis suppurativa (HS) demonstrates the utility of US in the diagnosis
04 mar 2026
Impact of smoking on disease severity
Smoking is associated with hidradenitis suppurativa (HS)
04 mar 2026
Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa
Hidradenitis suppurativa (HS) is a chronic relapsing, debilitating skin disease characterized by deep-seated nodules, abscesses and tunnels.
20 gen 2026
SIDeMaST Talk S2 - Puntata 3
Parliamo di Idrosadenite Suppurativa con la Prof.ssa Francesca Prignano
04 dic 2025
Effects of the ketogenic diet on skin
In recent years, interest in the impact of diet on the skin has increased significantly
04 giu 2025
European S2k guidelines
Second part of the S2k guidelines
05 mar 2025
Different Phenotypes of Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a chronic inflammatory disorder with a heterogeneous phenotype
05 feb 2025
Cute e Microbiota intestinale: update sulla relazione fra disbiosi e dermatosi
Il termine microbiota intestinale si riferisce all'insieme dei microrganismi, diversi miliardi, presenti nel tubo digerente
24 gen 2025
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2
This second part of the S2k guidelines is an update of the 2015 S1 European guidelines
04 dic 2024
Approved systemic drugs needed for dermatosis like alopecia areata
Approved systemic drugs needed for dermatosis
24 mag 2024
Improved clinical effectiveness of adalimumab
Adalimumab monotherapy for hidradenitis suppurativa (HS)
21 mag 2024
Idrosadenite suppurativa, tra ritardo diagnostico e social network
Il percorso del paziente alla ricerca del miglioramento della Qualità della vita
30 apr 2024
Jak Inhibitors e Idrosadenite Suppurativa
Idrosadenite Suppurativa, manifestazione e terapie
05 mar 2024
Efficacy and Safety of the Heat Shock Protein 90 Inhibitor RGRN-305
Hidradenitis suppurativa is a painful immune-mediated disorder with limited treatment options
24 nov 2023
Un aggiornamento per te da EADV 2023
Inibitori di JAK nelle indicazioni dermatologiche
25 ott 2023
Intervista Prof. Angelo Valerio Marzano
I Gruppi Italiano (Task Force della Sidemast) e i Gruppi Europei che si occupano di idrosadenite suppurativa si confrontano
25 ott 2023
Guselkumab for the treatment of patients
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that causes substantial physical